Breo Ellipta Alternatives in South Dakota
Compare generic and therapeutic alternatives to Breo Ellipta (fluticasone furoate / vilanterol) available at South Dakota pharmacies. Save up to 40% on your prescription — no insurance required.
Top Alternatives in South Dakota
Symbicort (budesonide/formoterol)
therapeutic
Twice-daily ICS/LABA — no generic but often lower retail price
Avg cash price: $380/mo
Wixela Inhub (generic Advair)
generic
FDA-approved generic ICS/LABA — significantly cheaper option
Avg cash price: $120/mo
Advair Diskus (fluticasone/salmeterol)
brand
Twice-daily ICS/LABA — has a generic available (Wixela)
Avg cash price: $450/mo
South Dakota Prescription Assistance Programs
South Dakota Medicaid Rx
Prescription drug coverage for South Dakota Medicaid beneficiaries.
Eligibility: South Dakota expanded Medicaid in 2023 (via ballot measure). Low-income adults up to 138% FPL, children, pregnant women, and people with disabilities.
Frequently Asked Questions
Is there a generic for Breo Ellipta?
No FDA-approved generic for Breo Ellipta exists as of 2025. The brand Ellipta device is patent-protected. Wixela Inhub is a generic for Advair Diskus and is a cheaper ICS/LABA alternative.
What is the cheapest once-daily COPD inhaler?
Breo Ellipta and Anoro Ellipta are once-daily brands without generics. Switching to a twice-daily generic like Wixela can reduce costs significantly — discuss with your pulmonologist.
How does Breo Ellipta differ from Symbicort?
Breo Ellipta is once-daily (fluticasone furoate/vilanterol); Symbicort is twice-daily (budesonide/formoterol). Both are ICS/LABA combinations but contain different molecules.
Can Script Unlock help reduce my Breo Ellipta cost?
Yes. Even without a generic, pharmacies compete on brand pricing. Script Unlock pharmacies sometimes offer lower cash prices than chain pharmacies on Breo Ellipta.
Can I switch from Breo Ellipta to Wixela to save money?
Wixela Inhub is an ICS/LABA inhaler at much lower cost, but the molecules differ slightly. Only your doctor or pulmonologist should make inhaler substitutions.